Products

Beta-Galactosidase

    • Product Name: Beta-Galactosidase
    • Factroy Site: Yudu County, Ganzhou, Jiangxi, China
    • Price Inquiry: admin@ascent-chem.com
    • Manufacturer: Ascent Petrochem Holdings Co., Limited
    • CONTACT NOW
    Specifications
    HS Code 291077
    Product Name Beta-Galactosidase
    Cas Number 9031-11-2
    Ec Number 3.2.1.23
    Molecular Formula N/A (protein enzyme)
    Molecular Weight Approximately 465 kDa (E. coli tetramer)
    Appearance Lyophilized powder or clear to light amber solution
    Solubility Soluble in water and dilute aqueous buffers
    Optimum Ph 6.5 to 7.5 (source-dependent)
    Optimum Temperature 37°C (source-dependent)
    Storage Conditions Store at 2-8°C; avoid repeated freeze-thaw cycles
    Substrate Lactose, o-nitrophenyl-beta-D-galactoside (ONPG)
    Specific Activity Typically 200-600 units per mg protein (source-dependent)

    As an accredited Beta-Galactosidase factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing Beta-Galactosidase, 5 g, supplied as lyophilized white powder in a sealed amber glass vial with desiccant.
    Container Loading (20′ FCL) 20′ FCL container loading of Beta-Galactosidase: packaged drums, secured pallets, temperature-controlled, labeled, and sealed for safe ocean transport.
    Shipping Beta-galactosidase is typically shipped as a lyophilized powder or buffered solution. Transport requires cold chain: freeze-dried forms may ship at ambient or +4°C, while liquid enzymes need +4°C or dry ice. Use insulated packaging with ice packs, avoid repeated freeze-thaw, and include temperature monitoring documentation.
    Storage Store beta-galactosidase lyophilized powder at -20°C in a desiccated, tightly sealed container, protected from light. For solutions, keep at 2–8°C for short-term use; for longer storage, add stabilizers such as 50% glycerol or BSA and freeze at -20°C. Avoid repeated freeze-thaw cycles to preserve enzymatic activity.
    Shelf Life Shelf life: stable for 12 months at -20°C; avoid repeated freeze-thaw cycles. Lyophilized powder lasts longer, refrigerated solutions shorter.
    Application of Beta-Galactosidase

    Batch lactase addition to pasteurised whole milk is carried out in jacketed silos with low-shear bottom agitation before UHT sterilisation. The enzyme preparation from Kluyveromyces lactis is dosed as a liquid or powder; typical addition ranges between 0.5–2.0 NLU/L when target residual lactose is below 0.1 g/100 mL. Hydrolysis proceeds at 4–8 °C for 12–24 h, which avoids mesophilic spore germination while neutral lactase remains active at pH 6.5–6.7. Initial lactose concentration in raw milk varies seasonally from 4.6–5.2 % (w/v); the holding time is adjusted against this value. In-process lactose concentration is monitored by ISO 22662:2007 HPLC-RI on samples drawn from the silo mid-depth. Production-line failure modes include pH drift caused by lactic acid bacteria in raw milk and premature enzyme inactivation when sodium hypochlorite residues from CIP enter the silo. Before enzyme injection, the silo is chilled to 4 °C and rinsing is continued until conductivity drops below 50 μS/cm. The enzyme preparation is added through a sterile dosing skid with positive displacement pump; batch-to-batch variation is corrected by FCC lactase unit assay. Hydrolysis is terminated by UHT final heating at 137–142 °C for 3–5 s in a tubular or plate steriliser, which denatures residual lactase. Terminal product is lactose-free whole milk, semi-skimmed milk or flavoured milk packed in aseptic cartons. Lactase from Kluyveromyces lactis is affirmed as GRAS under 21 CFR 184.1553. Final lactose content is verified after 7 days at 25 °C accelerated storage to detect post-pack hydrolysis from any surviving enzyme activity.

    Whey Permeate Lactose Hydrolysis and the Yeast Fermentation Bottleneck

    Sweet whey permeate generated after ultrafiltration of rennet cheese whey contains lactose at 4.0–4.5 % (w/v). Acid whey from Greek-style yogurt or quark lines presents pH 4.0–4.6; neutral lactase from Kluyveromyces lactis is inactive in this matrix. Acid lactase from Aspergillus oryzae is therefore applied without pH correction, with activity optimum at pH 3.5–4.5 and 45–55 °C. The substrate is held in a batch reactor with heating jacket and side-mounted mixer. Dose-response is adjusted to reduce lactose below 1.0 g/L for subsequent yeast fermentation of monosaccharides to ethanol or single-cell protein. Processing conflicts arise with pH correction: potassium hydroxide addition to raise acid whey pH above 6.0 destabilises calcium phosphate complexes and increases ash load. Published data for exact neutral lactase survival in acid whey are limited; process design should avoid neutral enzyme in acid streams unless ultrafiltration and diafiltration remove organic acids first. Hydrolysate is cooled to 30–32 °C before Saccharomyces cerevisiae inoculation in factory fermenters with working volumes up to 200 m³. Enzyme residues are inactivated during pasteurisation at 72 °C for 15 s. If hydrolysed whey concentrate is routed to spray drying, inlet air temperatures above 180 °C increase Maillard browning because reducing sugars are present. Final products are reduced-lactose whey syrup, bioethanol, or yeast biomass used in animal nutrition.

    How Does Transgalactosylation Shift Product Distribution in Concentrated Lactose Syrup?

    When lactose concentration is raised above 300 g/L, hydrolytic activity of β-galactosidase competes with transgalactosylation transfer to carbohydrate acceptors. Batch GOS synthesis is run in a stirred reactor at 50–60 °C, pH 4.5–6.0, with initial lactose dissolved in deionised water to 400–600 g/L. Dissolution requires heating to 70–80 °C before cooling to reaction temperature. The enzyme dose is expressed as total lactase activity per gram of lactose; commercial preparations from Aspergillus oryzae or Bifidobacterium bifidum are used. The reaction mixture develops a turbid appearance as galacto-oligosaccharides accumulate. Product distribution after 20–30 h includes unconverted lactose, glucose, galactose, and GOS species with degree of polymerisation from 2 to 6. Common literature values report GOS yield typically not exceeding 30–35 % of total carbohydrate under batch operation. Kinetic limitations are significant: glucose and galactose act as competitive inhibitors, and the ratio of hydrolysis to transfer is governed by water activity. Agitation speed above 300 rpm in a pilot-scale vessel improves mass transfer but increases air entrainment and may reduce enzyme stability. The reaction is stopped by heat treatment at 90 °C for 10 min. Terminal syrup is refined through activated carbon and ion-exchange demineralisation to produce a clear GOS concentrate of 45–55 % solids. GOS syrup is incorporated into infant formula and adult nutritional products under EU Regulation (EU) 2016/127 where applicable. No single ISO method covers all GOS species; GOS content is typically determined by HPAEC-PAD, while residual lactose is quantified by ISO 22662:2007.

    Lactose crystallisation defects in frozen dairy desserts are managed by adding neutral lactase at 0.5–1.5 NLU/L to the ice cream mix before high-temperature short-time pasteurisation at 85 °C for 20–30 s, with hydrolysis completed during subsequent ageing at 4 °C for 4–12 h; the terminal product is a soft-serve or hard-pack ice cream with reduced sandiness after storage at −18 °C. The enzyme preparation must conform to Food Chemicals Codex lactase activity specifications.

    Immobilised β-Galactosidase in Continuous Membrane Reactor Configurations

    Continuous lactose hydrolysis with enzyme immobilised on ion exchange resin is applied to whey permeate and retentate streams in dairy processing lines. The carrier is a styrene-divinylbenzene anion exchange resin with particle size 300–700 μm; enzyme is immobilised through glutaraldehyde crosslinking or covalent coupling. A packed bed reactor with aspect ratio above 3:1 and inlet distributor plate is operated at 30–40 °C for neutral lactase. Process control variables include pressure drop across the bed, substrate residence time, and enzyme leakage. In long-term runs, pressure drop above 1.5 bar may indicate resin fines accumulation or microbial biofilm growth. Backwashing with 0.1 M sodium acetate buffer at pH 5.0 restores flow. Continuous stirred tank reactors with membrane recirculation avoid bed compression but require ultrafiltration membranes with molecular weight cut-off 10–30 kDa to retain enzyme. Hydrolysis degree is controlled by feed flow rate and lactose load; residual lactose below 1.0 g/L in whey permeate is achievable at hydraulic retention times between 4–8 h. Terminal products are reduced-lactose whey concentrates and lactose-free milk ingredients for sports nutrition. Resin capacity is expressed as grams lactose hydrolysed per kilogram resin per hour; published data for exact capacity under industrial whey permeate are limited due to varying ash content. Microbial contamination in continuous reactors is managed by periodic sanitation with peracetic acid at 100–200 ppm after enzyme separation. Operational boundaries include divalent cation fouling on resin and enzyme thermal denaturation above 55 °C; cleaning with sodium hydroxide above 0.5 M may strip immobilised protein. Immobilised catalyst activity is verified with FCC lactase assay after desorption from resin.

    When Lactase Is Deployed as an Analytical Reagent for Lactose QC

    In quality control laboratories, β-galactosidase is used as a cleaving reagent in enzymatic lactose determination based on ISO 5765-1:2002 for dried milk and combined with glucose oxidase-peroxidase-linked chromogenic detection. Analytical-grade β-galactosidase from Escherichia coli or Kluyveromyces lactis is used; the preparation is free of glucose oxidase and hexokinase interference. The manual or automated assay proceeds at 37 °C and pH 6.6 in pipetting platforms with photometric read at 505 nm or 340 nm depending on the chromogen. Each millilitre of reagent contains sufficient β-galactosidase to hydrolyse the lactose present in 0.10 mL of diluted sample within 15 min. The method is linear up to 0.6 g/L lactose in the cuvette; higher concentrations require dilution with deionised water. Matrix interferences from galactose, glucose, and ascorbic acid are corrected with blank samples. The terminal output is a certificate of analysis for lactose content in milk powders, infant formula, and whey products. The enzyme reagent is stored lyophilised at 2–8 °C; reconstituted working solution remains stable for 24 h. Correlation between enzymatic and HPLC methods follows ISO 22662:2007 with a bias below 2 % for routine dairy matrices. Quality control laboratories follow ISO 5725-2 for repeatability and reproducibility verification.

    Free Quote

    Competitive Beta-Galactosidase prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615365186327

    Email: admin@ascent-chem.com

    Inquiry

    Get Free Quote of Ascent Petrochem Holdings Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Lactose hydrolysis in high-throughput dairy processing requires a β-galactosidase preparation with controlled side activities and reproducible activity retention under cold-storage dosing. Beta-Galactosidase BG-5000 is a liquid neutral lactase derived from a non-genetically modified Kluyveromyces lactis strain, standardised to 5,000 NLU/g using the FCC lactase unit assay. The enzyme belongs to EC 3.2.1.23 and hydrolyses the β-1→4 glycosidic bond in lactose, yielding D-glucose and D-galactose. In concentrated lactose streams above 30% w/w dry matter, the preparation also exerts transgalactosylation activity, producing galacto-oligosaccharides with β-linkages. The liquid formulation is clarified by ultrafiltration and contains polyol stabilisers to maintain activity during storage at 4–8°C for 12 months. The designation BG-5000 is a supplier-specific model code; equivalent activities are available under alternative trade designations, but the release specification below is product-specific.

    Table 1 — Representative release specification for Beta-Galactosidase BG-5000 liquid preparation
    ParameterSpecificationAnalytical method
    Declared lactase activity4,750–5,250 NLU/gFCC lactase unit assay
    pH optimum6.0–7.0Manufacturer technical data
    Temperature optimum40–45°CManufacturer technical data
    Total viable count≤ 1,000 CFU/gISO 4833-1:2013
    Yeast and mould count≤ 100 CFU/gISO 21527-1:2008
    Lead≤ 1 mg/kgICP-MS after acid digestion
    Arsenic≤ 1 mg/kgICP-MS after acid digestion
    Cadmium≤ 0.5 mg/kgICP-MS after acid digestion
    Mercury≤ 0.1 mg/kgICP-MS after acid digestion
    Stabiliser contentglycerol 50% w/w, sorbitol 10% w/wRefractive index/gas chromatography
    Allergensbelow detection limit for milk, soy, glutenValidated ELISA

    Activity standardisation is performed against a lactose substrate at 37°C and pH 6.5; one FCC lactase unit is defined as the quantity of enzyme that releases 1 μmol of glucose per minute under the specified assay. The liquid preparation contains potassium sorbate and sodium benzoate below regulatory maxima. It is filterable through 0.45 μm membrane filtration for aseptic process compatibility. The values in Table 1 are representative release specifications; the batch certificate governs for any individual lot.

    What Limits Industrial Lactose Conversion at Low Temperature?

    The critical constraint is low-temperature activity. At 4–8°C, the reaction rate of neutral lactase is approximately 20–30% of the optimum at 45°C, requiring longer holding times or higher dosage. Typical dosage for 4.5% w/w lactose skim milk is 1,500–3,500 NLU/L at 6°C for 24 h to achieve ≥ 70% lactose hydrolysis. In UHT lactose-free milk production, inline dosing before downstream sterilisation is carried out at 5–10 NLU/mL with a holding time of 2–4 h at 6–8°C. The enzyme loses activity above 50°C; pasteurisation at 75°C for 15 s inactivates residual activity. Manufacturer technical bulletins report half-life at 45°C below 2 h in dilute buffer without polyol stabilisers. Processing conflicts arise in high-shear dosing pumps because interfacial denaturation at air-liquid interfaces can reduce activity by 5–10% when recycle loops exceed 3 m/s linear velocity. The operative pH window is 6.0–7.5; below pH 5.5, activity declines rapidly and below pH 4.5 is negligible. Residual lactose in hydrolysate is determined by HPLC according to ISO 22662:2007 or equivalent anion-exchange chromatography with pulsed amperometric detection. This pH sensitivity differentiates the preparation from acid-stable fungal lactases used in acid whey.

    In whey permeate processing at 30% w/w dry matter, the preparation is dosed at 500–1,500 NLU/kg concentrate and held at 40°C for 2–4 h to reach 80–90% hydrolysis. The hydrolysate is then cooled to 4°C for crystallisation or fermentation. In high-solids systems, galactose inhibition becomes significant above 25% w/w monosaccharide concentration; the enzyme’s Km for lactose is typically 15–25 mM, but product inhibition by galactose can reduce effective rate by 30–50% when galactose exceeds 10% w/w. For galacto-oligosaccharide synthesis, initial lactose concentrations of 400–500 g/L favour transgalactosylation over hydrolysis, and GOS yields of 25–35% w/w on total sugars have been reported for neutral lactases under comparable conditions. Published data for this specific configuration is limited; however, jacketed stainless steel reactors with low-shear impellers are preferred because the substrate is soluble and high-shear dispersion is unnecessary. The hydrolysate should be cooled below 10°C within 30 min after target conversion to limit Maillard browning during storage.

    Comparison with Acid-Stable Fungal Beta-Galactosidase Preparations

    Two principal food-grade sources are used for lactose hydrolysis: Kluyveromyces lactis neutral lactase and Aspergillus oryzae acid lactase. BG-5000 has a pH optimum of 6.0–7.5, suitable for milk and sweet whey; A. oryzae lactase has a pH optimum of 3.5–5.0, suitable for acid whey and fermented dairy. The yeast enzyme is rapidly inactivated by pasteurisation at 75°C for 15 s; the fungal enzyme can retain activity at 50–60°C and may require higher thermal input for inactivation. The yeast preparation has negligible invertase activity, whereas fungal preparations may contain broader glycosidase side activities that alter oligosaccharide profiles. The neutral preparation is not suitable for acid whey below pH 4.5; an acid-stable variant must be selected. Conversely, the fungal acid lactase is less effective in milk at pH 6.7 because the reaction rate is far from its acid optimum.

    Table 2 — Comparative properties of neutral yeast lactase and acid-stable fungal lactase
    PropertyNeutral yeast lactase BG-5000Acid-stable fungal lactase
    Source organismKluyveromyces lactisAspergillus oryzae
    pH optimum6.0–7.53.5–5.0
    Temperature optimum40–45°C50–60°C
    Preferred substrate streamsMilk, sweet whey, neutral dairyAcid whey, fermented dairy
    Galacto-oligosaccharide formationModerate at 400–500 g/L lactoseLower due to hydrolysis bias
    Post-hydrolysis inactivationRapid at 75°C/15 sMay require higher temperature or pH shift
    Allergen statusYeast-derived; production aids removed by filtrationFungal-derived; mycotoxin absence per production strain

    Immobilised beta-galactosidase forms on methacrylate or epoxy-functionalised supports are available for continuous packed-bed reactors. BG-5000 as a soluble liquid differs in mass transfer limitations: immobilised systems exhibit apparent Km values up to 50–100 mM because of pore diffusion resistance, whereas the soluble preparation has a lower apparent Km. However, immobilised forms allow repeated batch operation and can reduce enzyme cost per kilogram of hydrolysed lactose after 20–50 cycles, though they require clarified substrates free of particulates larger than 10 μm to prevent bed plugging. The soluble preparation is preferred when downstream heat treatment is required because residual enzyme activity can be thermally destroyed; immobilised systems require separate sanitation protocols. Published data for this specific configuration is limited, but packed-bed reactors with 2–4 mm beads and a hydraulic residence time of 30–90 min have been reported for whey permeate.

    Compliance documentation for Beta-Galactosidase BG-5000 is maintained under EU Regulation 1332/2008 for food enzymes, FDA 21 CFR 184.1388 or equivalent GRAS determination for the production strain, and JECFA specifications for lactase from Kluyveromyces lactis. The preparation is tested for absence of antimicrobial activity by pharmacopoeial procedures. Certificates of analysis include lot-specific heavy metals and mycotoxin absence. Storage in unopened containers at 4–8°C is required; freezing below 0°C is not recommended for the liquid product because repeated freeze-thaw cycles can induce protein aggregation. The product should not be mixed with cationic flocculants or strong oxidising sanitisers; residual peroxides can oxidise active-site methionine residues. Avoid combination with amine-based additives in dry powder blends because pH increases can exceed the enzyme’s stability boundary. For continuous lactose hydrolysis in low-temperature milk lines, the operational boundary is 2–8°C with a maximum residence time of 48 h; longer processing windows increase microbial risk unless equipment is sanitised under ISO 14159 hygiene guidelines.

    Top